305 related articles for article (PubMed ID: 32255135)
1. Peptidomimetic toolbox for drug discovery.
Lenci E; Trabocchi A
Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
[TBL] [Abstract][Full Text] [Related]
2. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
Våbenø J; Haug BE; Rosenkilde MM
Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
[TBL] [Abstract][Full Text] [Related]
3. Limiting Assumptions in the Design of Peptidomimetics.
Marshall GR; Ballante F
Drug Dev Res; 2017 Sep; 78(6):245-267. PubMed ID: 28875546
[TBL] [Abstract][Full Text] [Related]
4. Dynamic combinatorial chemistry as a rapid method for discovering sequence-selective RNA-binding compounds.
McAnany JD; Miller BL
Methods Enzymol; 2019; 623():67-84. PubMed ID: 31239058
[TBL] [Abstract][Full Text] [Related]
5. Conformational Preferences and Antiproliferative Activity of Peptidomimetics Containing Methyl 1'-Aminoferrocene-1-carboxylate and Turn-Forming Homo- and Heterochiral Pro-Ala Motifs.
Kovačević M; Čakić Semenčić M; Radošević K; Molčanov K; Roca S; Šimunović L; Kodrin I; Barišić L
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948332
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry insights into antiviral peptidomimetics.
Ding D; Xu S; da Silva-Júnior EF; Liu X; Zhan P
Drug Discov Today; 2023 Mar; 28(3):103468. PubMed ID: 36528280
[TBL] [Abstract][Full Text] [Related]
7. Identification of constrained peptidomimetic chemotypes as HIV protease inhibitors.
Calugi C; Guarna A; Trabocchi A
Eur J Med Chem; 2014 Sep; 84():444-53. PubMed ID: 25042102
[TBL] [Abstract][Full Text] [Related]
8. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
Laxio Arenas J; Kaffy J; Ongeri S
Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight CXCR4 ligands with variable spacers.
Narumi T; Aikawa H; Tanaka T; Hashimoto C; Ohashi N; Nomura W; Kobayakawa T; Takano H; Hirota Y; Murakami T; Yamamoto N; Tamamura H
ChemMedChem; 2013 Jan; 8(1):118-24. PubMed ID: 23086703
[TBL] [Abstract][Full Text] [Related]
10. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
Shen K; Qi L; Stiff L
Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
[TBL] [Abstract][Full Text] [Related]
11. Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design.
Van der Poorten O; Knuhtsen A; Sejer Pedersen D; Ballet S; Tourwé D
J Med Chem; 2016 Dec; 59(24):10865-10890. PubMed ID: 27690430
[TBL] [Abstract][Full Text] [Related]
12. The potential for caspases in drug discovery.
MacKenzie SH; Schipper JL; Clark AC
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):568-76. PubMed ID: 20812148
[TBL] [Abstract][Full Text] [Related]
13. Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.
Li Petri G; Di Martino S; De Rosa M
J Med Chem; 2022 Jun; 65(11):7438-7475. PubMed ID: 35604326
[TBL] [Abstract][Full Text] [Related]
14. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
[TBL] [Abstract][Full Text] [Related]
15. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
Mizuno A; Matsui K; Shuto S
Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
[TBL] [Abstract][Full Text] [Related]
16. Rational modulator design by exploitation of protein-protein complex structures.
Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
[TBL] [Abstract][Full Text] [Related]
17. Peptides and peptidomimetics as regulators of protein-protein interactions.
Cunningham AD; Qvit N; Mochly-Rosen D
Curr Opin Struct Biol; 2017 Jun; 44():59-66. PubMed ID: 28063303
[TBL] [Abstract][Full Text] [Related]
18. Documenting and harnessing the biological potential of molecules in Distributed Drug Discovery (D3) virtual catalogs.
Abraham MM; Denton RE; Harper RW; Scott WL; O'Donnell MJ; Durrant JD
Chem Biol Drug Des; 2017 Nov; 90(5):909-918. PubMed ID: 28453915
[TBL] [Abstract][Full Text] [Related]
19. Peptidomimetics via modifications of amino acids and peptide bonds.
Avan I; Hall CD; Katritzky AR
Chem Soc Rev; 2014 May; 43(10):3575-94. PubMed ID: 24626261
[TBL] [Abstract][Full Text] [Related]
20. Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization.
Mizuno A; Kameda T; Kuwahara T; Endoh H; Ito Y; Yamada S; Hasegawa K; Yamano A; Watanabe M; Arisawa M; Shuto S
Chemistry; 2017 Mar; 23(13):3159-3168. PubMed ID: 28000361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
